1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,940 | 5,350 | 11:48 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.01. | Elekta AB: Elekta presents Strategic Update: growth, innovation, and operations | 328 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) today, at 14:00 CET, hosts its Strategic Update for investors, providing an overview of the company's strategic direction and ongoing transformation. The event, led by... ► Artikel lesen | |
| 16.01. | Elekta gets FDA nod for AI-powered linear accelerator for radiology | 6 | MassDevice | ||
| 26.11.25 | Elekta AB reports Q2 results | 11 | Seeking Alpha | ||
| 26.11.25 | Elekta AB Non-GAAP EPS of SEK 0.64, revenue of SEK 4.07B; reaffirms FY outlook | 7 | Seeking Alpha | ||
| 26.11.25 | Elekta AB: Second quarter, August-October 2025/26 | 403 | GlobeNewswire (Europe) | Second quarterIn constant exchange rates, net sales increased by 1 percent mainly driven by Europe. Reported sales in SEK decreased by 6 percent amounting to SEK 4,070 M (4,341).The book-to-bill ratio... ► Artikel lesen | |
| 06.11.25 | Elekta deepens presence in China with manufacturing and R&D assets | 9 | China Daily | ||
| ELEKTA AB ADR Aktie jetzt für 0€ handeln | |||||
| 29.09.25 | Elekta AB: Study shows MRI-guided adaptive radiotherapy with Elekta Unity improves patient-reported urinary symptoms in men with prostate cancer | 428 | GlobeNewswire (Europe) | Data from an international registry confirms that tracking changes in prostate anatomy and adjusting radiation at each treatment session can lead to better long-term quality of life
SAN FRANCISCO -... ► Artikel lesen | |
| 25.09.25 | Elekta AB: Elekta marks two millionth patient treated with Leksell Gamma Knife radiosurgery | 248 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) today announces that more than two million patients worldwide have now received Leksell Gamma Knife® radiosurgery. The two millionth treatment was recently carried out... ► Artikel lesen | |
| 08.09.25 | Dividendenbekanntmachungen (08.09.2025) | 8.355 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALPHABET INC CDR CA02080K1049 0,0341 CAD 0,0211 EUR ALPHABET INC CL A US02079K3059 0,21 USD 0,1791 EUR ALPHABET INC CL C US02079K1079 0... ► Artikel lesen | |
| 08.09.25 | Elekta Names Klara Eiritz Next CFO As Hägglöv Departs | 4 | RTTNews | ||
| 04.09.25 | Elekta AB: Report from the Annual General Meeting 2025 of Elekta | 455 | GlobeNewswire (Europe) | Elekta AB (publ) has held its Annual General Meeting on September 4, 2025. The statement at the Meeting from the President and CEO will be available on Elekta's website, www.elekta.com. Documents from... ► Artikel lesen | |
| 28.08.25 | Elekta AB: Interim report, First quarter May-July 2025/26 | 515 | GlobeNewswire (Europe) | First quarterIn constant exchange rates, net sales increased by 3 percent driven by Europe. Reported sales in SEK decreased by 5 percent amounting to SEK 3,646 M (3,825).Book-to-bill ratio of 1.05 (1.10)... ► Artikel lesen | |
| 23.07.25 | Elekta AB: Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy | 406 | GlobeNewswire (Europe) | New indication expands treatment options for neurosurgeons managing complex epilepsy cases
ATLANTA - Elekta (EKTA-B.ST) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k)... ► Artikel lesen | |
| 09.06.25 | Elekta AB: Elekta appoints Jakob Just-Bomholt as new President and CEO | 533 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today the appointment by the Board of Directors of Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.
Jakob, a... ► Artikel lesen | |
| 28.05.25 | Elekta AB: Year-end report May-April 2024/25 | 550 | GlobeNewswire (Europe) | Fourth quarterIn constant exchange rates, net sales increased by 6 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 5,156 M (5,023).Book-to-bill ratio... ► Artikel lesen | |
| 03.05.25 | Elekta AB: Clinical trial shows more precise radiotherapy using Elekta Unity MR-Linac preserves sexual function in men with prostate cancer | 380 | GlobeNewswire (Europe) | ERECT trial used MR-guidance to spare nerves and blood vessels essential for achieving and maintaining an erection
VIENNA - Elekta (EKTA-B.ST) today announced that use of its 1.5T Elekta Unity MR-Linac... ► Artikel lesen | |
| 07.03.25 | Dividendenbekanntmachungen (07.03.2025) | 19.386 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2177 EUR AEW UK REIT PLC GB00BWD24154 0,02 GBP EUR AMERISAFE INC US03071H1005 0... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FAMICORD | 5,000 | -1,96 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| SPINEWAY | 0,159 | +5,58 % | Spineway: 2025 annual results | Ecully, February 17, 2026 - 7:00 p.m. SPINEWAY2025 annual results Revenue up 4%Improved resultsStronger growth potential Condensed consolidated income statement20252024Pro forma* 2024ReportedIn thousands... ► Artikel lesen | |
| PETMED EXPRESS | 2,360 | +0,51 % | Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways | MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing... ► Artikel lesen | |
| QUIDELORTHO | 19,100 | -1,55 % | QuidelOrtho Corporation: QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio | Agreement adds new analyzer platforms and expands assay menu across key international marketsSAN DIEGO, Feb. 16, 2026 /PRNewswire/ -- QuidelOrtho has entered a long-term strategic supply... ► Artikel lesen | |
| ELEKTA | 5,385 | +1,32 % | Elekta AB: Elekta presents Strategic Update: growth, innovation, and operations | STOCKHOLM - Elekta (EKTA-B.ST) today, at 14:00 CET, hosts its Strategic Update for investors, providing an overview of the company's strategic direction and ongoing transformation. The event, led by... ► Artikel lesen | |
| STAAR SURGICAL | 16,210 | -0,46 % | What's Next: Staar Surgical's Earnings Preview | ||
| TELEFLEX | 105,00 | -0,94 % | Teleflex Q4 Loss Sharply Widens; Provides Weak FY26 Outlook; Shares Tumble 8.9% | WASHINGTON (dpa-AFX) - Specialty medical devices provider Teleflex Inc. (TFX) reported Thursday that net loss for the fourth quarter sharply widened to $714.33 million or $16.15 per share from... ► Artikel lesen | |
| NOVACYT | 0,402 | -2,66 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 03.03.2026 | Das Instrument 00W AU000000ASP3 ASPERMONT LTD EQUITY wird cum Kapitalmassnahme gehandelt am 03.03.2026 und ex Kapitalmassnahme am 04.03.2026 The instrument 00W AU000000ASP3 ASPERMONT LTD EQUITY is traded... ► Artikel lesen | |
| M3 INC | 9,100 | +0,55 % | M3, Inc. Nine Months Income Climbs | TOKYO (dpa-AFX) - M3, Inc. (4YC.F) released a profit for its nine months that Increased, from the same period last yearThe company's earnings came in at JPY41.650 billion, or JPY61.39 per share.... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 55,74 | +0,61 % | Inspire Medical shares steady as Evercore ISI maintains rating | ||
| AMBEA | 11,870 | -1,49 % | Ambea AB: Ambea Year-end Report January-December 2025 | Significant investments in future growth
CEO's statement:
In the last quarter of the year, we continued investing strongly in growth through acquisitions and new operations as well as through developing... ► Artikel lesen | |
| SHIP HEALTHCARE | 14,000 | 0,00 % | Ship Healthcare Holdings Inc Reveals Drop In Nine Months Profit | ||
| BUMRUNGRAD HOSPITAL | 4,920 | +0,41 % | Bumrungrad Hospital Dissolves Two Inactive Subsidiaries in Hong Kong | ||
| GENEDX | 74,20 | 0,00 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| PROGYNY | 17,600 | 0,00 % | KeyBanc senkt Kursziel für Progyny-Aktie aufgrund konservativer Schätzungen |
ELEKTA AB ADR gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 5,350 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ELEKTA AB ADR finden Sie auf Wallstreet Online.